| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +5178328.42% |
| VRNA | Verona Pharma Plc | $77.75B | +3622913.37% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +3042165.72% |
| ARGX | Argen X SE | $54.32B | +2531352.01% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +1823551.12% |
| ONC | BeiGene Ltd | $34.73B | +1618430.05% |
| RVMD | Revolution Medicines Inc | $30.63B | +1427127.27% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +1098422.88% |
| BNTX | BioNTech SE | $23.52B | +1095844.98% |
| INSM | Insmed Inc | $23.04B | +1073462.52% |
| ROIV | Roivant Sciences Ltd | $21.31B | +992849.52% |
| INCY | Incyte Corp | $19.46B | +906870.75% |
| MRNA | Moderna Inc | $18.90B | +880690.64% |
| GMAB | Genmab | $17.06B | +794695.98% |
| ASND | Ascendis Pharma A/S | $15.18B | +707258.47% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +685148.30% |
| SMMT | Summit Therapeutics Inc | $13.47B | +627676.74% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +605828.73% |
| EXEL | Exelixis Inc | $12.69B | +591375.40% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +591244.35% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +566484.95% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +561852.64% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +517330.29% |
| ABVX | Abivax | $10.29B | +479246.26% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +471649.45% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +463543.18% |
| CYTK | Cytokinetics Inc | $9.51B | +443087.90% |
| KRYS | Krystal Biotech Inc | $9.03B | +420522.20% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +393557.56% |
| IBRX | ImmunityBio Inc | $8.26B | +384978.41% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +379064.07% |
| TECH | Bio-Techne Corp | $7.53B | +350650.07% |
| MTSR | Metsera Inc | $7.40B | +344954.92% |
| PCVX | Vaxcyte Inc | $7.36B | +343011.97% |
| CORT | Corcept Therapeutics Inc | $6.96B | +324262.19% |
| MRUS | Merus N.V | $6.83B | +317975.51% |
| IMVT | Immunovant Inc | $6.81B | +317414.56% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +312783.96% |
| ACLX | Arcellx Inc | $6.67B | +310530.85% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +305811.22% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +302531.66% |
| CELC | Celcuity Inc | $6.48B | +301731.52% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +291486.54% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +286655.14% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +280962.70% |
| TGTX | TG Therapeutics Inc | $6.00B | +279558.42% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +277056.56% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +276234.16% |
| COGT | Cogent Biosciences Inc | $5.89B | +274531.41% |
| PTCT | PTC Therapeutics Inc | $5.86B | +272809.08% |
| APGE | Apogee Therapeutics Inc | $5.82B | +271208.96% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +266296.02% |
| BLTE | Belite Bio Inc | $5.59B | +260384.23% |
| CGON | Cg Oncology Inc | $5.35B | +249249.53% |
| LEGN | Legend Biotech Corp | $5.26B | +245242.94% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +244487.44% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +242593.60% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +240332.39% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +220349.04% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +220067.29% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +209798.24% |
| TVTX | Travere Therapeutics Inc | $4.41B | +205554.34% |
| AKRO | Akero Therapeutics Inc | $4.38B | +204014.31% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +202477.14% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +198621.05% |
| ERAS | Erasca Inc | $3.88B | +180509.71% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +180451.00% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +178224.30% |
| VKTX | Viking Therapeutics Inc | $3.67B | +170884.07% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +168839.01% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +167889.01% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +153665.24% |
| BEAM | Beam Therapeutics Inc | $3.28B | +152581.32% |
| DNLI | Denali Therapeutics Inc | $3.21B | +149319.64% |
| RCUS | Arcus Biosciences Inc | $3.01B | +140083.13% |
| DYN | Dyne Therapeutics Inc | $3.00B | +139702.00% |
| ORKA | ARCA biopharma Inc | $2.91B | +135469.08% |
| TNGX | Tango Therapeutics Inc | $2.83B | +131907.62% |
| GPCR | Structure Therapeutics Inc | $2.81B | +130849.22% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +127657.02% |
| RLAY | Relay Therapeutics Inc | $2.73B | +127131.07% |
| ALMS | Alumis Inc | $2.67B | +124197.04% |
| IRON | Disc Medicine Inc | $2.66B | +124049.62% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +123139.60% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +120307.34% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +119774.62% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +117398.61% |
| IMNM | Immunome Inc | $2.50B | +116502.92% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +115209.94% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +114046.33% |
| ETNB | 89bio Inc | $2.34B | +109080.63% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +107043.97% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +103221.88% |
| KOD | Kodiak Sciences Inc | $2.18B | +101536.15% |
| ZLAB | Zai Lab Ltd | $2.08B | +96595.73% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +94599.23% |
| MESO | Mesoblast Ltd | $2.02B | +93945.67% |
| TYRA | Tyra Biosciences Inc | $1.97B | +91823.20% |
| SION | Sionna Therapeutics Inc | $1.96B | +91125.41% |
| STOK | Stoke Therapeutics Inc | $1.96B | +91117.18% |
| NBTX | Nanobiotix | $1.94B | +90149.58% |
| AAPG | Ascentage Pharma Group International | $1.93B | +89959.91% |
| PHVS | Pharvaris NV | $1.92B | +89583.45% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +89116.50% |
| GLPG | Galapagos NV | $1.90B | +88358.86% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +87921.07% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +87012.71% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +86367.77% |
| ADMA | Adma Biologics Inc | $1.84B | +85630.98% |
| NVAX | Novavax Inc | $1.82B | +84872.23% |
| ZYME | Zymeworks BC Inc | $1.81B | +84348.88% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +84077.62% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +82847.68% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +82308.32% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +81958.82% |
| VCEL | Vericel Corp | $1.75B | +81361.69% |
| OCS | Oculis Holding AG | $1.74B | +81178.68% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +80813.34% |
| BHVN | Biohaven Ltd | $1.70B | +79083.22% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +79042.72% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +78285.18% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +78203.90% |
| ANAB | AnaptysBio Inc | $1.67B | +77944.68% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +77447.00% |
| ABCL | AbCellera Biologics Inc | $1.65B | +76951.08% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +76875.50% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +76436.78% |
| INVA | Innoviva Inc | $1.63B | +76014.75% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +75336.43% |
| NKTR | Nektar Therapeutics | $1.62B | +75286.29% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +75226.10% |
| QURE | uniQure N.V. | $1.59B | +73832.76% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +73491.88% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +72800.69% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +72401.52% |
| PGEN | Precigen Inc | $1.55B | +72223.32% |
| IMTX | Immatics N.V | $1.53B | +71365.72% |
| ARDX | Ardelyx Inc | $1.52B | +70909.98% |
| MBX | MBX Biosciences Inc | $1.52B | +70570.75% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +70011.74% |
| VIR | Vir Biotechnology Inc | $1.47B | +68272.61% |
| IMCR | Immunocore Holdings plc | $1.45B | +67456.96% |
| URGN | UroGen Pharma Ltd | $1.43B | +66473.11% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +65815.65% |
| GHRS | GH Research PLC | $1.39B | +64537.69% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +63865.34% |
| SEPN | Septerna Inc | $1.34B | +62253.54% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +62153.77% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +61045.82% |
| MAZE | Maze Therapeutics Inc | $1.30B | +60277.72% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +59059.93% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +57899.81% |
| TRML | Tourmaline Bio Inc | $1.24B | +57484.53% |
| WVE | Wave Life Sciences Ltd | $1.22B | +56724.73% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +52488.58% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +52439.81% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +51077.83% |
| MNKD | Mannkind Corp | $1.10B | +51002.31% |
| DBVT | DBV Technologies | $1.10B | +50943.41% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +50567.45% |
| SVRA | Savara Inc | $1.07B | +49652.01% |
| JBIO | Jade Biosciences Inc | $1.06B | +49339.51% |
| CVAC | CureVac N.V. | $1.05B | +48797.42% |
| ANNX | Annexon Inc | $1.05B | +48677.80% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +46440.03% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +46027.60% |
| CGEM | Cullinan Oncology Inc | $953.73M | +44343.41% |
| PHAR | Pharming Group N.V. | $940.58M | +43730.96% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +42948.30% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +42484.64% |
| KURA | Kura Oncology Inc | $908.93M | +42256.10% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +42101.71% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +41276.58% |
| JANX | Janux Therapeutics Inc | $878.90M | +40856.43% |
| XNCR | Xencor Inc | $868.03M | +40350.02% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +39659.46% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +39232.61% |
| GERN | Geron Corp | $843.41M | +39202.85% |
| EVMN | Evommune Inc | $841.03M | +39091.78% |
| VOR | Vor Biopharma Inc | $840.96M | +39088.57% |
| TBPH | Theravance Biopharma Inc | $837.63M | +38933.57% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +38796.84% |
| SANA | Sana Biotechnology Inc | $825.64M | +38374.66% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +37436.24% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +37047.50% |
| OMER | Omeros Corporation | $797.02M | +37041.19% |
| ABSI | Absci Corp | $789.28M | +36680.44% |
| CMRX | Chimerix Inc | $766.03M | +35596.84% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +35385.88% |
| ANRO | Alto Neuroscience Inc | $714.55M | +33197.88% |
| ATXS | Astria Therapeutics Inc | $709.95M | +32983.57% |
| DSGN | Design Therapeutics Inc | $693.10M | +32198.31% |
| SLDB | Solid Biosciences Inc | $690.73M | +32087.92% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +31735.05% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +31373.97% |
| CRMD | CorMedix Inc | $663.22M | +30806.11% |
| IVA | Inventiva | $655.21M | +30432.87% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +30064.40% |
| CABA | Cabaletta Bio Inc | $640.38M | +29741.78% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +29705.70% |
| PRME | Prime Medicine Inc | $596.03M | +27674.93% |
| CADL | Candel Therapeutics Inc | $589.73M | +27381.10% |
| CBIO | Crescent Biopharma Inc | $573.22M | +26611.96% |
| TECX | AvroBio Inc | $573.01M | +26602.16% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +26523.01% |
| ARVN | Arvinas Inc | $570.83M | +26500.33% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +25568.89% |
| VALN | Valneva SE | $545.52M | +25321.25% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +25193.70% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +25097.24% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +24984.61% |
| MDXG | Mimedx Group Inc | $537.64M | +24954.02% |
| PRTA | Prothena Corporation plc | $532.36M | +24708.08% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +24130.69% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +23285.48% |
| XOMA | XOMA Corp | $497.12M | +23065.56% |
| STRO | Sutro Biopharma Inc | $491.87M | +22820.97% |
| OCGN | Ocugen Inc | $466.88M | +21656.52% |
| SVA | Sinovac Biotech Ltd | $464.94M | +21566.05% |
| IMMX | Immix Biopharma Inc | $462.80M | +21466.18% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +21457.26% |
| STTK | Shattuck Labs Inc | $458.03M | +21243.90% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +20944.60% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +20935.66% |
| UPB | Upstream Bio Inc | $449.51M | +20847.03% |
| AUTL | Autolus Therapeutics plc | $447.12M | +20735.74% |
| ADCT | Adc Therapeutics SA | $438.08M | +20314.62% |
| ASMB | Assembly Biosciences Inc | $435.45M | +20191.90% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +20050.89% |
| AURA | Aura Biosciences Inc | $430.49M | +19960.71% |
| OVID | Ovid Therapeutics Inc | $424.86M | +19698.24% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +19453.10% |
| IPSC | Century Therapeutics Inc | $415.14M | +19245.25% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +18956.33% |
| CMPX | Compass Therapeutics Inc | $408.80M | +18949.98% |
| CYBN | Cybin Inc | $408.43M | +18932.85% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +18715.28% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +18689.76% |
| BNTC | Benitec Biopharma Inc | $398.51M | +18470.50% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +18087.15% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +18082.69% |
| CCCC | C4 Therapeutics Inc | $389.10M | +18031.79% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +18002.74% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +17762.38% |
| RVNC | Revance Therapeutics Inc | $380.38M | +17625.49% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +17612.97% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +17472.85% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +17467.36% |
| OABI | OmniAb Inc | $374.99M | +17374.46% |
| REPL | Replimune Group Inc | $374.27M | +17340.74% |
| ALT | Altimmune Inc | $373.67M | +17313.17% |
| VSTM | Verastem Inc | $373.33M | +17297.23% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +17278.16% |
| PBYI | Puma Biotechnology Inc | $371.93M | +17231.72% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +16940.05% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +16868.07% |
| EDIT | Editas Medicine Inc | $349.39M | +16181.28% |
| PALI | Palisade Bio Inc | $346.56M | +16049.76% |
| RGNX | Regenxbio Inc | $345.32M | +15991.74% |
| IMRX | Immuneering Corp Class A | $344.95M | +15974.82% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +15947.75% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +15896.92% |
| FBRX | Forte Biosciences Inc | $340.15M | +15751.02% |
| IMAB | I-Mab | $339.64M | +15726.97% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +15490.52% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +15216.81% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +15118.60% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +15104.57% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +15058.93% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +14978.28% |
| SLN | Silence Therapeutics Plc | $321.20M | +14867.64% |
| RZLT | Rezolute Inc | $319.69M | +14797.51% |
| IVVD | Invivyd Inc | $319.57M | +14791.82% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +14744.88% |
| ANL | Adlai Nortye Ltd | $317.46M | +14693.36% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +14115.74% |
| SCPH | scPharmaceuticals Inc | $304.59M | +14093.85% |
| NAGE | Niagen Bioscience Inc | $304.32M | +14081.26% |
| SRZN | Surrozen Inc | $304.03M | +14067.52% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +14013.30% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +13685.23% |
| IRD | Ocuphire Pharma Inc | $295.61M | +13675.19% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +13382.25% |
| ACIU | AC Immune SA | $289.11M | +13372.60% |
| TENX | Tenax Therapeutics Inc | $288.39M | +13339.05% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +13229.76% |
| YDES | YD Bio Ltd | $278.91M | +12897.13% |
| MGNX | Macrogenics Inc | $278.39M | +12873.06% |
| FATE | Fate Therapeutics Inc | $275.57M | +12741.31% |
| CNTX | Context Therapeutics Inc | $273.80M | +12659.02% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +12606.85% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +12446.26% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +12188.36% |
| TARA | Protara Therapeutics Inc | $262.06M | +12112.16% |
| CGEN | Compugen Ltd | $260.97M | +12061.00% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +11893.89% |
| CHRS | Coherus Biosciences Inc | $256.00M | +11829.60% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +11819.02% |
| HUMA | Humacyte Inc | $255.32M | +11797.95% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +11582.28% |
| ALEC | Alector Inc | $245.37M | +11333.99% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +11194.37% |
| THRD | Third Harmonic Bio Inc | $241.86M | +11170.84% |
| CDXS | Codexis Inc | $239.96M | +11082.09% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +10945.10% |
| ADAG | Adagene Inc | $236.93M | +10940.79% |
| NKTX | Nkarta Inc | $236.88M | +10938.70% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +10758.31% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +10692.11% |
| NERV | Minerva Neurosciences Inc | $230.61M | +10646.33% |
| SLRN | Acelyrin Inc | $228.54M | +10550.12% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +10412.89% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +10359.58% |
| CRBU | Caribou Biosciences Inc | $223.96M | +10336.37% |
| KROS | Keros Therapeutics Inc | $223.18M | +10300.07% |
| RNA | Atrium Therapeutics Inc | $222.37M | +10262.55% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +10087.07% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +10045.72% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +9480.50% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +9333.90% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +9304.12% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +9254.99% |
| KRRO | Korro Bio Inc | $198.45M | +9147.94% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +9118.14% |
| DTIL | Precision Biosciences Inc | $195.87M | +9027.35% |
| IMUX | Immunic Inc | $190.70M | +8786.62% |
| QTTB | Q32 Bio Inc | $187.99M | +8660.23% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +8550.43% |
| MDWD | MediWound Ltd | $184.49M | +8496.98% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +8449.11% |
| THAR | Tharimmune Inc | $183.00M | +8427.75% |
| IFRX | InflaRx N.V. | $182.18M | +8389.46% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +8325.78% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +8214.85% |
| GALT | Galectin Therapeutics Inc | $177.81M | +8186.08% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +7987.06% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +7943.09% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +7942.92% |
| HRTX | Heron Therapeutics Inc | $172.54M | +7940.33% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +7909.80% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +7868.39% |
| SPRO | Spero Therapeutics Inc | $169.62M | +7804.35% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +7788.40% |
| THTX | Theratechnologies Inc | $167.34M | +7697.85% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +7664.15% |
| EQ | Equillium Inc | $166.29M | +7648.89% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +7584.87% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +7559.38% |
| MENS | Jyong Biotech Ltd | $164.22M | +7552.64% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +7490.44% |
| IPHA | Innate Pharma | $159.97M | +7354.62% |
| TTRX | Turn Therapeutics Inc | $157.58M | +7243.14% |
| MOLN | Molecular Partners AG | $154.89M | +7117.63% |
| VXRT | Vaxart Inc | $153.61M | +7058.28% |
| HURA | TuHURA Biosciences Inc | $151.32M | +6951.34% |
| NBP | NovaBridge Biosciences. | $150.91M | +6932.47% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +6913.64% |
| AKTX | Akari Therapeutics Plc | $148.12M | +6802.57% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +6673.58% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +6601.88% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +6575.76% |
| PROK | ProKidney Corp - Class A | $137.85M | +6323.79% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +6313.35% |
| GNLX | Genelux Corp | $137.21M | +6294.04% |
| GUTS | Fractyl Health Inc | $136.31M | +6252.07% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +6068.28% |
| AGEN | Agenus Inc | $131.36M | +6021.31% |
| ACOG | Alpha Cognition Inc | $124.77M | +5714.05% |
| CRDF | Cardiff Oncology Inc | $123.75M | +5666.71% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +5514.32% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +5493.37% |
| SEER | Seer Inc - Class A | $115.64M | +5288.90% |
| ENGN | enGene Holdings Inc | $115.22M | +5269.32% |
| RPTX | Repare Therapeutics Inc | $113.91M | +5208.29% |
| COYA | Coya Therapeutics Inc | $111.89M | +5114.09% |
| PYXS | Pyxis Oncology Inc | $108.70M | +4965.31% |
| VANI | Vivani Medical Inc | $108.35M | +4949.06% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +4855.00% |
| HLVX | HilleVax Inc | $104.74M | +4780.81% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +4770.39% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +4751.20% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +4706.72% |
| PEPG | PepGen Inc | $103.13M | +4705.75% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +4671.97% |
| BMEA | Biomea Fusion Inc | $98.33M | +4482.03% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +4457.62% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +4454.68% |
| ICCC | Immucell Corp | $96.17M | +4381.38% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +4277.43% |
| ATHA | Athira Pharma Inc | $92.15M | +4194.19% |
| FBIO | Fortress Biotech Inc | $91.60M | +4168.32% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +4133.72% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +4080.77% |
| ANIX | Anixa Biosciences Inc | $88.68M | +4032.38% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +4005.29% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +3964.27% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +3956.39% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +3953.73% |
| PYPD | Polypid Ltd | $86.83M | +3946.40% |
| NRXS | Neuraxis Inc | $85.30M | +3875.09% |
| LPTX | Leap Therapeutics Inc | $84.76M | +3849.74% |
| CSBR | Champions Oncology Inc | $82.35M | +3737.44% |
| ACET | Adicet Bio Inc | $81.58M | +3701.63% |
| HYFT | MindWalk Holdings Corp | $79.54M | +3606.63% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +3603.74% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +3531.21% |
| FBIOP | Fortress Biotech Inc | $77.72M | +3521.74% |
| RLYB | Rallybio Corp | $76.87M | +3481.99% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +3477.66% |
| GANX | Gain Therapeutics Inc | $75.20M | +3404.53% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +3380.24% |
| XBIT | XBiotech Inc | $74.39M | +3366.56% |
| OSTX | OS Therapies Inc | $74.24M | +3359.37% |
| MCRB | Seres Therapeutics Inc | $73.19M | +3310.61% |
| SAVA | Cassava Sciences Inc. | $72.46M | +3276.71% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +3251.74% |
| EDSA | Edesa Biotech Inc | $70.82M | +3200.16% |
| BYSI | BeyondSpring Inc | $70.31M | +3176.66% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +3102.00% |
| SPRB | Spruce Biosciences Inc | $67.96M | +3066.70% |
| CUE | Cue Biopharma Inc | $66.52M | +2999.97% |
| IMA | Ikena Oncology Inc | $66.48M | +2998.09% |
| MNOV | Medicinova Inc | $65.46M | +2950.62% |
| IBIO | iBio Inc | $64.94M | +2926.28% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +2897.15% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +2882.30% |
| IMMP | Immutep Ltd | $63.92M | +2878.73% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +2861.57% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +2847.07% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +2846.04% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +2787.11% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +2754.31% |
| GLTO | Galecto Inc | $60.81M | +2733.72% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +2658.69% |
| ANVS | Annovis Bio Inc | $57.22M | +2566.31% |
| DWTX | Virios Therapeutics Inc | $57.12M | +2561.62% |
| ENTX | Entera Bio Ltd | $55.48M | +2485.38% |
| TIL | Instil Bio Inc | $55.21M | +2472.55% |
| KZR | Kezar Life Sciences Inc | $53.76M | +2405.17% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +2361.98% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +2356.31% |
| NBY | Stablecoin Development Corp | $52.10M | +2327.76% |
| RNTX | Rein Therapeutics Inc | $51.79M | +2313.61% |
| GOSS | Gossamer Bio Inc | $51.14M | +2283.13% |
| MGX | Metagenomi Inc | $50.82M | +2268.37% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +2231.46% |
| INKT | MiNK Therapeutics Inc | $48.84M | +2176.02% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +2157.26% |
| XLO | Xilio Therapeutics Inc | $48.23M | +2147.34% |
| CING | Cingulate Inc | $47.16M | +2097.50% |
| ATYR | Atyr Pharma Inc | $46.89M | +2084.98% |
| LVTX | LAVA Therapeutics NV | $45.77M | +2032.93% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +2030.85% |
| PSTV | Plus Therapeutics Inc | $45.56M | +2023.27% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +1954.59% |
| KALA | Kala Bio Inc | $43.31M | +1918.44% |
| RNXT | RenovoRx Inc | $41.96M | +1855.21% |
| NTRB | Nutriband Inc | $41.39M | +1828.82% |
| HYPD | Eyenovia Inc | $41.14M | +1817.23% |
| FGEN | FibroGen Inc | $39.31M | +1731.66% |
| NNVC | NanoViricides Inc | $37.88M | +1665.29% |
| VERU | Veru Inc | $37.40M | +1642.70% |
| LTRN | Lantern Pharma Inc | $37.25M | +1635.98% |
| INMB | INmune Bio Inc | $37.22M | +1634.41% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +1610.62% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +1582.48% |
| GRCE | Acasti Pharma Inc | $36.05M | +1580.13% |
| GBIO | Generation Bio Company | $35.97M | +1576.13% |
| ABVC | ABVC BioPharma Inc | $35.82M | +1569.07% |
| MURA | Mural Oncology plc | $35.34M | +1546.95% |
| LITS | Lite Strategy Inc | $35.16M | +1538.26% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +1514.86% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +1498.35% |
| DARE | Dare Bioscience Inc | $33.92M | +1480.83% |
| EVAX | Evaxion Biotech A/S | $33.82M | +1475.99% |
| BOLD | Boundless Bio Inc | $32.94M | +1434.92% |
| SNTI | Senti Biosciences Inc | $31.46M | +1365.85% |
| TVRD | Cara Therapeutics Inc | $30.96M | +1342.66% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +1300.51% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +1296.74% |
| APLM | Apollomics Inc - Class A | $29.93M | +1294.76% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +1258.31% |
| SKYE | Skye Bioscience Inc | $29.10M | +1256.18% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +1253.15% |
| GRDX | Entero Therapeutics Inc | $28.95M | +1249.21% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +1232.10% |
| CRVO | CervoMed Inc | $28.15M | +1211.62% |
| IGC | IGC Pharma Inc | $28.00M | +1204.74% |
| DYAI | Dyadic International Inc DE | $27.40M | +1176.75% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +1175.29% |
| SER | AgeX Therapeutics Inc | $26.82M | +1149.72% |
| PLRZ | Polyrizon Ltd | $26.52M | +1135.84% |
| CELU | Celularity Inc - Class A | $26.39M | +1129.74% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +1128.30% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +1126.47% |
| PTN | Palatin Technologies Inc | $26.08M | +1115.12% |
| TPST | Tempest Therapeutics Inc | $25.68M | +1096.49% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +1077.31% |
| PLUR | Pluri Inc | $24.62M | +1047.13% |
| MRKR | Marker Therapeutics Inc | $24.21M | +1028.41% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +1009.65% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +956.73% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +939.95% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +931.15% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +923.14% |
| NXTC | Nextcure Inc | $21.90M | +920.44% |
| OPT | Opthea Ltd | $21.53M | +903.27% |
| CRIS | Curis Inc | $21.11M | +883.66% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +849.53% |
| LGVN | Longeveron Inc - Class A | $19.70M | +818.14% |
| GNTA | Genenta Science SpA | $19.23M | +795.93% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +795.78% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +780.69% |
| XCUR | Exicure Inc | $17.78M | +728.69% |
| INAB | IN8bio Inc | $17.72M | +725.97% |
| PASG | Passage Bio Inc | $17.71M | +725.15% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +705.29% |
| MTVA | MetaVia Inc | $17.25M | +703.80% |
| LPCN | Lipocine Inc | $17.04M | +694.21% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +671.29% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +651.05% |
| HIND | ReShape Lifesciences Inc | $15.72M | +632.62% |
| COCP | Cocrystal Pharma Inc | $15.44M | +619.57% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +619.49% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +610.11% |
| QNCX | Quince Therapeutics Inc | $14.89M | +594.06% |
| APLT | Applied Therapeutics Inc | $14.86M | +592.61% |
| HOOK | Hookipa Pharma Inc | $14.68M | +583.96% |
| BLRX | Bioline Rx Ltd | $14.66M | +583.34% |
| MBRX | Moleculin Biotech Inc | $14.57M | +578.88% |
| IOBT | IO Biotech Inc | $14.50M | +575.62% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +568.12% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +559.22% |
| GTBP | GT Biopharma Inc | $13.91M | +548.08% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +536.80% |
| TOVX | Theriva Biologics Inc | $13.51M | +529.39% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +522.57% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +506.76% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +505.30% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +495.50% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | +474.74% |
| CALC | CalciMedica Inc | $11.72M | +446.37% |
| LNAI | Lunai Bioworks Inc | $11.72M | +445.94% |
| TRAW | Traws Pharma Inc | $11.70M | +445.10% |
| INTS | Intensity Therapeutics Inc | $11.33M | +428.01% |
| BIVI | BioVie Inc - Class A | $11.16M | +420.14% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | +419.20% |
| BRTX | BioRestorative Therapies Inc | $11.03M | +413.97% |
| APRE | Aprea Therapeutics Inc | $10.96M | +410.71% |
| KAPA | Kairos Pharma Ltd | $10.68M | +397.88% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +385.87% |
| CVM | Cel-Sci Corp | $10.15M | +372.78% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | +371.90% |
| MLEC | Moolec Science SA | $10.06M | +368.67% |
| BCDA | BioCardia Inc | $9.85M | +358.99% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | +356.96% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | +353.38% |
| SNGX | Soligenix Inc | $9.11M | +324.32% |
| IMNN | Imunon Inc | $9.02M | +320.44% |
| EPIX | Essa Pharma Inc | $8.93M | +316.18% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +315.55% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | +309.98% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | +305.60% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | +297.93% |
| IMRN | Immuron Ltd | $8.36M | +289.47% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | +280.21% |
| LIMN | Liminatus Pharma Inc | $8.08M | +276.43% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +275.65% |
| NCNA | NuCana plc | $7.95M | +270.39% |
| ADXN | Addex Therapeutics Ltd | $7.90M | +268.08% |
| SYBX | Synlogic Inc | $7.72M | +259.81% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | +257.18% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +241.85% |
| XBIO | Xenetic Biosciences Inc | $7.06M | +229.22% |
| GNPX | Genprex Inc | $7.02M | +227.20% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | +225.33% |
| EVGN | Evogene Ltd | $6.91M | +222.20% |
| SILO | SILO Pharma Inc | $6.78M | +216.09% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | +214.28% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | +211.44% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +198.24% |
| GOVX | Geovax Labs Inc | $6.29M | +192.90% |
| APM | Aptorum Group Ltd - Class A | $6.26M | +191.51% |
| BCAB | BioAtla Inc | $6.19M | +188.47% |
| PPBT | Purple Biotech Ltd | $6.05M | +181.91% |
| APVO | Aptevo Therapeutics Inc | $5.83M | +171.50% |
| BGMS | Bio Green Med Solution Inc | $5.30M | +146.92% |
| DRMA | Dermata Therapeutics Inc | $5.23M | +143.66% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | +141.34% |
| HCWB | HCW Biologics Inc | $5.10M | +137.54% |
| PULM | Pulmatrix Inc | $4.97M | +131.47% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | +128.79% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | +128.58% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | +118.07% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | +117.50% |
| ALZN | Alzamend Neuro Inc | $4.38M | +103.90% |
| MBIO | Mustang Bio Inc | $4.29M | +99.93% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | +98.76% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | +98.70% |
| REVB | Revelation Biosciences Inc | $4.26M | +98.52% |
| FBLG | FibroBiologics Inc | $4.23M | +96.92% |
| ENVB | Enveric Biosciences Inc | $4.15M | +93.51% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | +92.85% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | +90.15% |
| PHGE | BiomX Inc | $3.91M | +82.02% |
| PBM | Psyence Biomedical Ltd | $3.76M | +75.36% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | +73.25% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | +68.08% |
| VIVS | VivoSim Labs Inc | $3.36M | +56.77% |
| XRTX | XORTX Therapeutics Inc | $3.34M | +55.73% |
| AZTR | Azitra Inc | $3.32M | +54.76% |
| GRI | GRI Bio Inc | $3.30M | +53.62% |
| SPRC | SciSparc Ltd | $3.05M | +41.92% |
| AFMD | Affimed N.V. | $2.98M | +38.64% |
| CMND | Clearmind Medicine Inc | $2.88M | +34.30% |
| ENSC | Ensysce Biosciences Inc | $2.88M | +34.03% |
| ARTL | Artelo Biosciences Inc | $2.75M | +27.97% |
| OGEN | Oragenics Inc | $2.58M | +20.10% |
| PPCB | Propanc Biopharma Inc | $2.50M | +16.58% |
| NTBL | Notable Labs Inc Ord | $2.39M | +11.59% |
| BBLG | Bone Biologics Corp | $2.23M | +3.74% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -2.70% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -7.07% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -18.72% |
| ONCO | Onconetix Inc | $1.61M | -24.89% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -27.36% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -27.56% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -27.61% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -29.20% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -33.51% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -35.49% |
| JAGX | Jaguar Health Inc | $1.34M | -37.39% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -39.34% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -53.04% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -57.13% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -74.32% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -79.18% |
| ELAB | PMGC Holdings Inc | $221376.00 | -89.68% |
| ADTX | Aditxt Inc | $132564.52 | -93.82% |
| CDT | CDT Equity Inc | $110551.31 | -94.85% |